Immunome, Inc. - Common Stock (NQ:IMNM)
Price and Volume
Detailed Quote| Volume | 992,139 |
| Open | 17.71 |
| Bid (Size) | 18.03 (400) |
| Ask (Size) | 18.07 (200) |
| Prev. Close | 17.14 |
| Today's Range | 17.35 - 18.79 |
| 52wk Range | 5.150 - 18.45 |
| Shares Outstanding | 87,012,328 |
| Dividend Yield | N/A |
Top News
More News
Performance
More News
Read More
Where Immunome Stands With Analysts ↗
September 22, 2025
Where Immunome Stands With Analysts ↗
September 05, 2025
Infinimmune Announces Research Collaboration with Immunome
September 18, 2025
Immunome Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
September 04, 2025
Immunome (IMNM) Q2 Revenue Surges 382% ↗
August 06, 2025
These stocks are moving in today's after hours session ↗
June 30, 2025
Immunome to Present at Upcoming Investor Conferences
May 22, 2025
Frequently Asked Questions
Is Immunome, Inc. - Common Stock publicly traded?
Yes, Immunome, Inc. - Common Stock is publicly traded.
What exchange does Immunome, Inc. - Common Stock trade on?
Immunome, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Immunome, Inc. - Common Stock?
The ticker symbol for Immunome, Inc. - Common Stock is IMNM on the Nasdaq Stock Market
What is the current price of Immunome, Inc. - Common Stock?
The current price of Immunome, Inc. - Common Stock is 18.05
When was Immunome, Inc. - Common Stock last traded?
The last trade of Immunome, Inc. - Common Stock was at 11/17/25 02:43 PM ET
What is the market capitalization of Immunome, Inc. - Common Stock?
The market capitalization of Immunome, Inc. - Common Stock is 1.57B
How many shares of Immunome, Inc. - Common Stock are outstanding?
Immunome, Inc. - Common Stock has 2B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.